Pfizer to help 23andMe unravel genetic ties to bowel disease
August 12, 2014 at 13:56 PM EDT
Aug 12 (Reuters) - Home genetics company 23andMe on Tuesday said it hopes to uncover gene mutations linked to inflammatory bowel disease (IBD) by enrolling 10,000 people with the hard-to-treat malady and examining DNA from their donated saliva samples.
